SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.

Patents, Intellectual Property News

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. · TAMPA, FL, May 19, 2025 (GLOBE NEWSWIRE) ...

Read More
GlobeNewswire News Room
Source
Patents, Intellectual Property
CATEGORY
May 19, 2025
PUBLISHED DATE
3
No.of views

Related articles